Trump Signs Executive Order to Fast-Track Psychedelic Drug Research and Access
President Donald Trump recently signed an executive order to accelerate the approval process for psychedelic therapies, including psilocybin and ibogaine. The move is expected to boost research and commercialization, impacting mental health treatment options.
· 46d ago
